Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 24,734 Shares of Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 24,734 shares of Privia Health Group stock in a transaction that occurred on Thursday, July 2nd. The shares were sold at an average price of $27.50, for a total transaction of $680,185.00. Following the completion of the sale, the chief financial officer owned 186,728 shares in the company, valued at $5,135,020. This trade represents a 11.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Friday, June 26th, David Mountcastle sold 17,196 shares of Privia Health Group stock. The shares were sold at an average price of $25.18, for a total transaction of $432,995.28.
• On Monday, May 11th, David Mountcastle sold 3,385 shares of Privia Health Group stock. The shares were sold at an average price of $22.60, for a total transaction of $76,501.00.
• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total transaction of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The stock was sold at an average price of $25.03, for a total transaction of $179,690.37.

Privia Health Group Price Performance

Shares of NASDAQ PRVA opened at $27.23 on Wednesday. The business has a 50-day moving average of $23.59 and a 200-day moving average of $23.06. The stock has a market capitalization of $3.43 billion, a price-to-earnings ratio of 170.20, a PEG ratio of 2.15 and a beta of 0.83. Privia Health Group, Inc. has a fifty-two week low of $18.77 and a fifty-two week high of $27.70.

Hedge Funds Weigh In On Privia Health Group

Several institutional investors and hedge funds have recently modified their holdings of the stock. GAMMA Investing LLC lifted its stake in shares of Privia Health Group by 14.0% during the 2nd quarter. GAMMA Investing LLC now owns 4,819 shares of the company’s stock worth $124,000 after buying an additional 592 shares during the last quarter. State of Alaska Department of Revenue raised its holdings in Privia Health Group by 1.3% in the 4th quarter. State of Alaska Department of Revenue now owns 65,747 shares of the company’s stock valued at $1,558,000 after acquiring an additional 823 shares during the period. PNC Financial Services Group Inc. raised its holdings in Privia Health Group by 8.8% in the 1st quarter. PNC Financial Services Group Inc. now owns 10,361 shares of the company’s stock valued at $213,000 after acquiring an additional 840 shares during the period. ProShare Advisors LLC lifted its position in Privia Health Group by 4.1% during the fourth quarter. ProShare Advisors LLC now owns 22,576 shares of the company’s stock worth $535,000 after acquiring an additional 898 shares during the last quarter. Finally, Vanguard Personalized Indexing Management LLC lifted its position in Privia Health Group by 5.9% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 16,250 shares of the company’s stock worth $385,000 after acquiring an additional 903 shares during the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on PRVA shares. Weiss Ratings upgraded Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 2nd. Barclays lowered their target price on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. Evercore set a $26.00 price target on shares of Privia Health Group in a research report on Wednesday, April 8th. Finally, Canaccord Genuity Group decreased their price objective on shares of Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $31.15.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.